HAEMONETICS CORP — Director's Dealing 2019

Nov 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-11-11

Reporting Person: Bolorforosh Said (EVP, Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-11	Common Stock	S	339	$118.27	Disposed	1977	Direct

Footnotes

F1: This number includes unvested restricted stock units previously reported.